Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
---|
05/09/2007 | EP1781593A2 Cationic lipids and methods of use |
05/09/2007 | CN1960965A Synthesis of amino-alkoxy-heptanoic alkyl ester |
05/09/2007 | CN1314655C Method for preparing 4-nitroso-substituted aromatic amine |
05/08/2007 | US7214806 Synthetic multiple quaternary ammonium salts |
05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
05/03/2007 | WO2007051198A2 Photo-responsive microencapsulation materials, compositions and methods of use thereof |
05/03/2007 | WO2007014973A3 Method of obtaining phenyl carbamates |
05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
05/03/2007 | US20070099079 Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery |
05/03/2007 | CA2627648A1 Photo-responsive microencapsulation materials, compositions and methods of use thereof |
05/02/2007 | EP1778619A2 T type calcium channel inhibitors |
05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
05/02/2007 | EP1322590B1 5-amino-1-pentene-3-ol substituted derivatives |
05/02/2007 | EP1299342B1 Method for producing 3,3-diarylpropylamines |
05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
05/02/2007 | CN1956970A Substituted pyrazinecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agricultural/horticultural agent and use thereof |
05/02/2007 | CN1956969A 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and 5-serotonin reuptake inhibitors |
05/02/2007 | CN1956945A P-terphenyl compound and photosensitive body for electrophotography using such compound |
05/02/2007 | CN1955159A Composite for blocking 5-hydroxytryptamine and norepinephrine reabsorbed, its preparation method and its use |
05/01/2007 | US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor |
05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
05/01/2007 | US7211685 Carboxy group, nitro group, tert-butoxycarbonylamino group or benzyloxycarbonylamino substituted naphthalene: osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia |
05/01/2007 | CA2271004C Process for the preparation of optically pure isomers of formoterol |
04/26/2007 | WO2007047972A2 Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride |
04/26/2007 | WO2007045857A1 Novel process |
04/26/2007 | WO2007017267A3 Novel compounds |
04/26/2007 | WO2006072785A3 Base stable ionic liquids |
04/26/2007 | WO2006072775A3 Ionic liquids with a cation comprising a basic moiety |
04/26/2007 | US20070093556 Toremifene crystallization method |
04/26/2007 | US20070093476 Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
04/26/2007 | CA2838520A1 Novel process |
04/26/2007 | CA2625832A1 Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride |
04/26/2007 | CA2625337A1 Novel process |
04/25/2007 | EP1777214A2 Novel aryloxy-alkyl-dialkylamines |
04/25/2007 | CN1312535C Optical photoresist stripping composition |
04/25/2007 | CN1312125C Amino alcohol derivative, addition salt thereof, and immunosuppressant |
04/25/2007 | CN1312116C Calcium acceptor active compound |
04/25/2007 | CN1312115C Chiral 1,4 diamidogen and its complex of platinum II |
04/25/2007 | CN1312114C Compound of aroma dihydroxy diamines and preparation method |
04/25/2007 | CN1312111C Process for preparing 2-[(dimethylamino)-methyl]-1-(3-methoxyphenyl)cyclohexanol |
04/24/2007 | USRE39593 Diastereoisomers with an analgesic effect; suitable for the treatment of severe pain without the side effects of opioids |
04/24/2007 | USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations |
04/24/2007 | US7208520 Crystals of hydroxynorephedrine derivative |
04/19/2007 | WO2007017544A3 Method of obtaining 3,3-diphenylpropylamines |
04/18/2007 | CN1950385A Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts |
04/18/2007 | CN1950326A Process for the optical resolution and recycling of tomoxetine |
04/18/2007 | CN1950325A Process for the preparation of atomoxetine hydrochloride |
04/18/2007 | CN1948277A Propylamine derivative and its application in preparing tomocetin |
04/18/2007 | CN1948276A Improved preparation method of flurazetin |
04/18/2007 | CN1948275A Verakanol Mannich alkali derivative, its preparation method and use |
04/18/2007 | CN1948274A Verakanol derivative, its preparation method and use |
04/18/2007 | CN1948266A Method of preparing N-mono substituted benzylamine by catalytic hydrogenation reduction amination |
04/18/2007 | CN1948265A Nitrobenzene derivative containing phenoxy and its preparation method |
04/18/2007 | CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I |
04/18/2007 | CN1310871C Preparation of N-methylated amines from selective vapor phase amination of amino ether alcohols |
04/17/2007 | US7205425 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof |
04/17/2007 | US7205320 Such as 3-[3-(4-chlorophenyl)prop-1-yloxy]-4-methoxy-N-(3-pyridylmethyl)diphenylamine; reduced emetic side effect; neurological syndromes |
04/17/2007 | CA2348725C Vitamin d analogues |
04/12/2007 | WO2007039125A2 An optically active thyroid receptor agonist and optically active key intermediates in its production |
04/12/2007 | WO2007021462A3 Alkylamino alkyloxy (alcohol) monoalkyl ether for acid gas scrubbing process |
04/12/2007 | WO2007015002A3 Novel crystalline iv form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
04/12/2007 | WO2006136682A3 Method for preparing fatty-chain branched triamines and ether diamines |
04/11/2007 | EP1439164B1 Novel phenylethanolamine compounds having beta2-acceptor excitatory function and their preparation method |
04/11/2007 | EP1228035B1 Laundry detergent compositions comprising hydrophobically modified polyamines |
04/11/2007 | EP1207868B1 Pharmaceutical tramadol salts |
04/11/2007 | EP0787122B1 Calcium receptor-active compounds |
04/11/2007 | CN1946679A Amino-propanol derivatives |
04/11/2007 | CN1946678A Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards |
04/11/2007 | CN1946677A Enantiomerically pure atomoxetine and tomoxetine mandelate |
04/10/2007 | US7202348 Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs |
04/10/2007 | US7202242 Substituted 1 and 2-naphthol Mannich bases |
04/10/2007 | CA2337991C Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
04/05/2007 | WO2007036781A1 Diphenyl ether monoamine reuptake inhibitor |
04/05/2007 | WO2007036712A1 Ionic liquids |
04/05/2007 | WO2007036496A1 Method for preparing aminodiglycol (adg) and morpholine |
04/05/2007 | US20070078139 Phosphodiesterase 4 inhibitors |
04/05/2007 | US20070077506 Electrophotographic photoreceptor and image forming apparatus provided with the same |
04/04/2007 | EP1770083A1 Inorganic ion receptor-active compounds |
04/04/2007 | EP1768949A2 Polymorphs of atomoxetiene hydrochloride |
04/04/2007 | EP1332139B1 Anticancer agents based on regulation of protein prenylation |
04/04/2007 | CN1942429A Processes for the preparation of tomoxetine |
04/04/2007 | CN1939891A Pharmaceutical synthesis of 4-methoxy-alpha-methyl-phenethylamine |
04/04/2007 | CN1308332C Method for preparation of aryl ethers |
04/04/2007 | CN1308283C Intermediate in producing phenoxyacetic acid derivatives and method for using same |
04/03/2007 | US7199239 Chemical compounds |
03/29/2007 | WO2007034924A1 METALLO-β-LACTAMASE INHIBITOR |
03/29/2007 | US20070072859 Pharmaceutical compounds |
03/29/2007 | CA2620675A1 Metallo-.beta.-lactamase inhibitors |
03/28/2007 | EP1765267A1 Initial phenylpropanediol dye products |
03/28/2007 | EP1138745B1 Organic electroluminescent element |
03/28/2007 | CN1938262A Quaternary ammonium compound, method for production thereof, and therapeutic agent for cerebrovascular disorder and heat disease |
03/27/2007 | USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations |
03/27/2007 | US7196225 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof |
03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
03/27/2007 | US7196084 Cdc25 phosphatase inhibitors |
03/27/2007 | CA2180841C 1-aminoindan derivatives and compositions thereof |
03/22/2007 | WO2006133339A3 Monoamine re-uptake inhibitors and methods relating thereto |
03/22/2007 | US20070066658 N-{4-[4-(2-Benzylamino-ethyl)-phenoxy]-phenyl}-acetamide; eating disorders; antidiabetic, -arthritic, -epileptic, anxiolytic -lipedemic agents; anxiolytic, hypoglycemic and hypotensive agents; sexual disorders, antidepressants, hypertriglycemia, hyperlipoproteinemia, drug abuse; behavior disorders |
03/21/2007 | CN1934071A Formamide derivatives useful as adrenoceptor |
03/21/2007 | CN1934067A Preparation of levalbuterol hydrochloride |